fluorouracil has been researched along with Atypical Ductal Hyperplasia in 64 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated whether capecitabine and docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide (FEC) or weekly paclitaxel (WP) followed by FEC would improve relapse-free survival (RFS) in operable breast cancer." | 9.16 | Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer. ( Booser, DJ; Brewster, AM; Broglio, K; Buzdar, AU; Gonzalez-Angulo, AM; Green, MC; Hortobagyi, GN; Hunt, KK; Ibrahim, NK; Kelly, CM; Thomas, ES; Valero, V; Walters, RS, 2012) |
| "Forty-three patients with nonmetastatic inflammatory breast carcinoma have been treated by initial doxorubicin, 5-fluorouracil, and cyclophosphamide (FAC) combination chemotherapy." | 7.68 | Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast. ( Bergerat, JP; Boilletot, A; Duclos, B; Dufour, P; Giron, C; Haennel, P; Herbrecht, R; Jaeck, D; Jung, G; Maloisel, F, 1990) |
| " Accordingly, the feasibility and toxicity of 6 courses of adjuvant chemotherapy with cyclophosphamide (C), epirubicin (E), and 5-fluorouracil (F) were assessed in 10 patients with Stage 2 (node positive) breast cancer." | 7.67 | Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer. ( Brooks, BD; Jones, SE; Knox, SM; McGuffey, P; Mennel, RG; Peters, GN; Westrick, MA, 1988) |
| "A case of metastatic infiltrating breast cancer in a young multiparous lady with 33 weeks pregnancy is presented who was treated with combination chemotherapy and hemostatic radiotherapy and had successful pregnancy outcome." | 5.35 | Successful pregnancy outcome with 5-flurouracil, epirubicin, cyclophosphamide chemotherapy, and hemostatic radiotherapy with abdominal shielding for metastatic invasive intraductal breast carcinoma. ( Kumar, S; Malhotra, N; Pushparaj, M; Raina, V; Roy, KK; Sharma, JB, 2009) |
| "We investigated whether capecitabine and docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide (FEC) or weekly paclitaxel (WP) followed by FEC would improve relapse-free survival (RFS) in operable breast cancer." | 5.16 | Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer. ( Booser, DJ; Brewster, AM; Broglio, K; Buzdar, AU; Gonzalez-Angulo, AM; Green, MC; Hortobagyi, GN; Hunt, KK; Ibrahim, NK; Kelly, CM; Thomas, ES; Valero, V; Walters, RS, 2012) |
| "Forty-three patients with nonmetastatic inflammatory breast carcinoma have been treated by initial doxorubicin, 5-fluorouracil, and cyclophosphamide (FAC) combination chemotherapy." | 3.68 | Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast. ( Bergerat, JP; Boilletot, A; Duclos, B; Dufour, P; Giron, C; Haennel, P; Herbrecht, R; Jaeck, D; Jung, G; Maloisel, F, 1990) |
| "A 57-year-old woman developed severe tumor lysis syndrome characterized by acute hyperuricemic nephropathy, hyperphosphatemia, hyperkalemia, and hypocalcemia after therapy with cyclophosphamide, methotrexate, and 5-fluorouracil for metastatic infiltrating ductal carcinoma of the breast involving the chest wall, lungs, pleurae, and liver." | 3.67 | Tumor lysis syndrome in nonhematopoietic neoplasms. ( Barton, JC, 1989) |
| " Accordingly, the feasibility and toxicity of 6 courses of adjuvant chemotherapy with cyclophosphamide (C), epirubicin (E), and 5-fluorouracil (F) were assessed in 10 patients with Stage 2 (node positive) breast cancer." | 3.67 | Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer. ( Brooks, BD; Jones, SE; Knox, SM; McGuffey, P; Mennel, RG; Peters, GN; Westrick, MA, 1988) |
| "Adjacent ductal carcinoma in situ (DCIS) is found in approximately 45% of invasive ductal carcinomas (IDC) of the breast." | 1.38 | Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40). ( Clemens, MR; Darb-Esfahani, S; Denkert, C; Diebold, K; Dietrich, K; Eidtmann, H; Hanusch, C; Henschen, S; Hoffmann, G; Holms, F; Huober, J; Just, M; Loibl, S; Schrader, I; Solbach, C; Tesch, H; Tiemann, K; Untch, M; von Minckwitz, G, 2012) |
| "One hundred and fourteen cases of breast cancer with NA therapy were analyzed and clinical data were collected from March 2007 to December 2010." | 1.37 | [Primary systemic therapy in breast cancer patients (2007-2010)]. ( Farkas, R; Horváth, OP; Kálmán, E; Kovács, G; Kövér, E; Pavlovics, G; Szalai, G; Tizedes, G; Zapf, I, 2011) |
| "A case of metastatic infiltrating breast cancer in a young multiparous lady with 33 weeks pregnancy is presented who was treated with combination chemotherapy and hemostatic radiotherapy and had successful pregnancy outcome." | 1.35 | Successful pregnancy outcome with 5-flurouracil, epirubicin, cyclophosphamide chemotherapy, and hemostatic radiotherapy with abdominal shielding for metastatic invasive intraductal breast carcinoma. ( Kumar, S; Malhotra, N; Pushparaj, M; Raina, V; Roy, KK; Sharma, JB, 2009) |
| "Although studies have focused on modulating the bioavailability of 5-FU through inhibition of dihydropyrimidine dehydrogenase (DPD) to improve efficacy of the drug, activity of this enzyme in breast cancer has not been thoroughly examined." | 1.32 | Increased dihydropyrimidine dehydrogenase activity in breast cancer. ( Abe, Y; Anan, K; Iwashita, T; Mitsuyama, S; Nishihara, K; Ogawa, Y; Suehara, N; Tamae, K; Toyoshima, S, 2003) |
| "First, the patient developed severe encephalopathy following a high-dose chemotherapy protocol commonly used in the treatment of metastatic breast carcinoma and second, the encephalopathy involved primarily deep gray matter structures rather than white matter." | 1.32 | Fatal chemotherapy-induced encephalopathy following high-dose therapy for metastatic breast cancer: a case report and review of the literature. ( Cossaart, N; Johnson, P; Preston, D; SantaCruz, KS; Skikne, BS, 2003) |
| "As a prerequisite four human breast cancer cell lines (MDA-MB-231, MCF-7, T-47-D and ZR-75-1) were characterized with regard to oestrogen and progesterone receptor content, modal chromosome number and proliferation kinetics depending on the number of passages in culture." | 1.28 | Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. ( Bernhardt, G; Birnböck, H; Reile, H; Schönenberger, H; Spruss, T, 1992) |
| "The level of structural chromosomal aberrations two years after the therapeutic treatment was 0." | 1.28 | [Chromosomal restructurings and the distribution of chromosome fragile sites in the peripheral blood lymphocytes in a breast cancer patient after cytostatic therapy]. ( Iakovleva, TK; Moiseenko, VM; Monakhov, AS, 1992) |
| "IL-6-treated dividing breast carcinoma cells are characterized by an increased probability of separation from neighbors and the substratum." | 1.28 | Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis. ( Cardinale, I; Murphy, JS; Tamm, I, 1991) |
| "Eighty-one patients with operable breast cancers received the short-term and intensive preoperative chemotherapy, followed by radical mastectomy are presented." | 1.28 | [Preoperative intensive chemotherapy of operable breast cancer]. ( Zhang, B, 1989) |
| "Case report of a 45-year-old woman with breast cancer who underwent mastectomy with axillary lymphonodectomy and radiation therapy." | 1.28 | [Ablative hormone therapy and chemotherapy of metastatic breast cancer]. ( Blaschke, U; Gerber, B; Kasch, R, 1989) |
| "In 41 cases of primary breast cancer preoperative treatment was performed using 2 methods consisting CPA + FT-207 (5-FUDS) (for Group I) and CPA + FT-207 (5-FUDS) + MMC (for Group II) to determine clinical and histological efficacies." | 1.27 | [Clinical study on preoperative chemotherapy of primary breast cancer. 2--A comparative study of CPA + FT-207 (5-FUDS) and CPA + FT-207 (5-FUDS) + MMC]. ( Andoh, H; Fujii, Y; Gotoh, M; Hagiwara, H; Hara, Y; Kataoka, J; Kobayashi, T; Komuro, K; Nagasaki, Y; Nagayama, A; Nakamura, K; Nakamura, R, 1983) |
| "One partial remission out of 7 cases of stomach cancer was obtained, and its duration was 40 weeks." | 1.27 | [Clinical trial on the effect of tegafur (SF-SP)]. ( Akazawa, S; Futatsuki, K; Hattori, M; Ishibashi, I; Kanda, Y; Sendai, H; Shimada, S, 1984) |
| "Three patients with metastatic breast carcinoma who had untreated locally advanced primary tumors were treated initially with combination chemotherapy followed by hygienic mastectomy." | 1.26 | Mastectomy as an adjunct to combination chemotherapy. ( Aisner, J; Elias, EG; Morris, D; Wiernik, PH, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (43.75) | 18.7374 |
| 1990's | 24 (37.50) | 18.2507 |
| 2000's | 5 (7.81) | 29.6817 |
| 2010's | 7 (10.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nozoe, T | 1 |
| Nozoe, E | 1 |
| Iguchi, T | 1 |
| Ito, S | 1 |
| Ohga, T | 1 |
| Koga, T | 1 |
| Ezaki, T | 1 |
| Narui, K | 1 |
| Ishikawa, T | 1 |
| Satake, T | 1 |
| Adachi, S | 1 |
| Yamada, A | 1 |
| Shimada, K | 1 |
| Shimizu, D | 1 |
| Kida, K | 1 |
| Sugae, S | 1 |
| Ichikawa, Y | 1 |
| Tanabe, M | 1 |
| Sasaki, T | 1 |
| Endo, I | 1 |
| Boekel, NB | 1 |
| Schaapveld, M | 1 |
| Gietema, JA | 1 |
| Russell, NS | 1 |
| Poortmans, P | 1 |
| Theuws, JC | 1 |
| Schinagl, DA | 1 |
| Rietveld, DH | 1 |
| Versteegh, MI | 1 |
| Visser, O | 1 |
| Rutgers, EJ | 1 |
| Aleman, BM | 1 |
| van Leeuwen, FE | 1 |
| Nemec, MJ | 1 |
| Kim, H | 1 |
| Marciante, AB | 1 |
| Barnes, RC | 1 |
| Talcott, ST | 1 |
| Mertens-Talcott, SU | 1 |
| Sharma, JB | 1 |
| Pushparaj, M | 1 |
| Kumar, S | 1 |
| Roy, KK | 1 |
| Raina, V | 1 |
| Malhotra, N | 1 |
| von Minckwitz, G | 1 |
| Darb-Esfahani, S | 1 |
| Loibl, S | 1 |
| Huober, J | 1 |
| Tesch, H | 1 |
| Solbach, C | 1 |
| Holms, F | 1 |
| Eidtmann, H | 1 |
| Dietrich, K | 1 |
| Just, M | 1 |
| Clemens, MR | 1 |
| Hanusch, C | 1 |
| Schrader, I | 1 |
| Henschen, S | 1 |
| Hoffmann, G | 1 |
| Tiemann, K | 1 |
| Diebold, K | 1 |
| Untch, M | 1 |
| Denkert, C | 1 |
| Zapf, I | 1 |
| Tizedes, G | 1 |
| Pavlovics, G | 1 |
| Kovács, G | 1 |
| Kálmán, E | 1 |
| Szalai, G | 1 |
| Kövér, E | 1 |
| Farkas, R | 1 |
| Horváth, OP | 1 |
| Kelly, CM | 1 |
| Green, MC | 1 |
| Broglio, K | 1 |
| Thomas, ES | 1 |
| Brewster, AM | 1 |
| Valero, V | 1 |
| Ibrahim, NK | 1 |
| Gonzalez-Angulo, AM | 1 |
| Booser, DJ | 1 |
| Walters, RS | 1 |
| Hunt, KK | 1 |
| Hortobagyi, GN | 2 |
| Buzdar, AU | 2 |
| Anan, K | 1 |
| Mitsuyama, S | 1 |
| Tamae, K | 1 |
| Suehara, N | 1 |
| Nishihara, K | 1 |
| Ogawa, Y | 1 |
| Abe, Y | 1 |
| Iwashita, T | 1 |
| Toyoshima, S | 1 |
| Cossaart, N | 1 |
| SantaCruz, KS | 1 |
| Preston, D | 1 |
| Johnson, P | 1 |
| Skikne, BS | 1 |
| Nixon, DW | 1 |
| Shlaer, SM | 1 |
| Komuro, K | 1 |
| Hara, Y | 1 |
| Fujii, Y | 1 |
| Nagayama, A | 1 |
| Kobayashi, T | 1 |
| Gotoh, M | 1 |
| Hagiwara, H | 1 |
| Nakamura, R | 1 |
| Nagasaki, Y | 1 |
| Kataoka, J | 1 |
| Andoh, H | 1 |
| Nakamura, K | 1 |
| Ohyama, K | 1 |
| Koike, D | 1 |
| Odake, Y | 1 |
| Takiyama, Y | 1 |
| Saitoh, T | 1 |
| Kagaya, T | 1 |
| Takebe, T | 1 |
| Ishii, K | 1 |
| Futatsuki, K | 1 |
| Shimada, S | 1 |
| Kanda, Y | 1 |
| Ishibashi, I | 1 |
| Sendai, H | 1 |
| Akazawa, S | 1 |
| Hattori, M | 1 |
| Hann, SK | 1 |
| Rhoe, BS | 1 |
| Kang, WH | 1 |
| Park, YK | 1 |
| Willett, CG | 1 |
| Lewandrowski, K | 1 |
| Warshaw, AL | 1 |
| Efird, J | 1 |
| Compton, CC | 1 |
| Calais, G | 1 |
| Descamps, P | 1 |
| Chapet, S | 1 |
| Turgeon, V | 1 |
| Reynaud-Bougnoux, A | 1 |
| Lemarié, E | 1 |
| Fignon, A | 1 |
| Body, G | 1 |
| Bougnoux, P | 1 |
| Lansac, J | 1 |
| Foo, ML | 1 |
| Gunderson, LL | 1 |
| Nagorney, DM | 1 |
| McLlrath, DC | 1 |
| van Heerden, JA | 1 |
| Robinow, JS | 1 |
| Kvols, LK | 1 |
| Garton, GR | 1 |
| Martenson, JA | 1 |
| Cha, SS | 1 |
| Ehlinger, P | 1 |
| Peeters, LC | 1 |
| Servais, J | 1 |
| Fossion, E | 1 |
| Han, S | 1 |
| Ahn, SH | 1 |
| Park, K | 1 |
| Bae, BN | 1 |
| Kim, KH | 1 |
| Kim, HJ | 1 |
| Kim, YD | 1 |
| Kim, HY | 1 |
| Domoto, H | 1 |
| Tsuda, H | 1 |
| Miyakawa, K | 1 |
| Shinoda, A | 1 |
| Nanasawa, T | 1 |
| Elias, K | 1 |
| Fisher, B | 1 |
| Glass, A | 1 |
| Redmond, C | 1 |
| Fisher, ER | 1 |
| Barton, B | 1 |
| Such, E | 1 |
| Carbone, P | 1 |
| Economou, S | 1 |
| Foster, R | 1 |
| Frelick, R | 1 |
| Lerner, H | 1 |
| Levitt, M | 1 |
| Margolese, R | 1 |
| MacFarlane, J | 1 |
| Plotkin, D | 1 |
| Shibata, H | 1 |
| Volk, H | 1 |
| Morris, D | 1 |
| Aisner, J | 1 |
| Elias, EG | 2 |
| Wiernik, PH | 1 |
| Bernhardt, G | 1 |
| Reile, H | 1 |
| Birnböck, H | 1 |
| Spruss, T | 1 |
| Schönenberger, H | 1 |
| Bocklage, T | 1 |
| Lee, KR | 1 |
| Belinson, JL | 1 |
| Jaiyesimi, IA | 1 |
| Iakovleva, TK | 1 |
| Monakhov, AS | 1 |
| Moiseenko, VM | 1 |
| Kuusk, U | 1 |
| Basco, V | 1 |
| Rebbeck, P | 1 |
| Cheson, BD | 1 |
| Ungerleider, RS | 1 |
| Harris, BE | 1 |
| Carpenter, JT | 1 |
| Diasio, RB | 1 |
| Ziegler, LD | 1 |
| Connelly, JH | 1 |
| Frye, D | 1 |
| Smith, TL | 1 |
| Sbalzarini, G | 1 |
| Pandolfi, C | 1 |
| Labadini, A | 1 |
| Cascinelli, N | 1 |
| Greco, M | 1 |
| Morabito, A | 1 |
| Bufalino, R | 1 |
| Testori, A | 1 |
| Baldini, MT | 1 |
| Andreola, S | 1 |
| Leo, E | 1 |
| Galluzzo, D | 1 |
| Rilke, F | 1 |
| Sidorova, NA | 1 |
| Volchenko, NN | 2 |
| Saribekian, EK | 1 |
| Vowden, P | 1 |
| Wilkinson, D | 1 |
| Kester, RC | 1 |
| Tamm, I | 1 |
| Cardinale, I | 1 |
| Murphy, JS | 1 |
| Frank, GA | 1 |
| Borisov, VI | 1 |
| Schreer, I | 1 |
| Frischbier, HJ | 1 |
| Maass, H | 1 |
| Stegner, HE | 1 |
| Chen, LJ | 1 |
| Zhang, SY | 1 |
| Zhang, Z | 1 |
| Shu, YH | 1 |
| Zhang, JL | 1 |
| Maloisel, F | 1 |
| Dufour, P | 1 |
| Bergerat, JP | 1 |
| Herbrecht, R | 1 |
| Duclos, B | 1 |
| Boilletot, A | 1 |
| Giron, C | 1 |
| Jaeck, D | 1 |
| Haennel, P | 1 |
| Jung, G | 1 |
| Dunphy, FR | 1 |
| Spitzer, G | 1 |
| Lomeo, AM | 1 |
| Avolio, C | 1 |
| Iacobellis, G | 1 |
| Manzione, L | 1 |
| Nunnink, JC | 1 |
| Krusinski, PA | 1 |
| Yates, JW | 1 |
| Barton, JC | 1 |
| Masuoka, H | 1 |
| Asaishi, K | 1 |
| Toda, K | 1 |
| Okazaki, M | 1 |
| Okazaki, Y | 1 |
| Hayasaka, H | 1 |
| Miyake, H | 1 |
| Mori, M | 1 |
| Shimizu, T | 1 |
| Fujimori, M | 1 |
| Takahashi, S | 1 |
| Komatsu, M | 1 |
| Masuda, H | 1 |
| Kobayashi, S | 1 |
| Sugenoya, A | 1 |
| Senga, O | 1 |
| Iida, F | 1 |
| Zhang, B | 1 |
| Kasch, R | 1 |
| Gerber, B | 1 |
| Blaschke, U | 1 |
| Jones, SE | 1 |
| Mennel, RG | 1 |
| Peters, GN | 1 |
| Westrick, MA | 1 |
| Brooks, BD | 1 |
| Knox, SM | 1 |
| McGuffey, P | 1 |
| Wang, ZY | 1 |
| Serrano Migallón, JA | 1 |
| Sandoval Guerrero, F | 1 |
| Miranda Hernández, H | 1 |
| de la Garza Navarro, JM | 1 |
| Tuchman, M | 1 |
| Stoeckeler, JS | 1 |
| Kiang, DT | 1 |
| O'Dea, RF | 1 |
| Ramnaraine, ML | 1 |
| Mirkin, BL | 1 |
| Morris, DM | 1 |
| Didolkar, MS | 1 |
| Brown, SD | 1 |
| Marymont, JV | 1 |
| Kaufman, EE | 1 |
| Linsk, JA | 1 |
| Emerman, JT | 1 |
| Fiedler, EE | 1 |
| Tolcher, AW | 1 |
| Rebbeck, PM | 1 |
| Close, PM | 1 |
| Tiltman, AJ | 1 |
| Hacking, EA | 1 |
| Holmes, FA | 1 |
| Obbens, EA | 1 |
| Griffin, E | 1 |
| Lee, YY | 1 |
| Izsak, FC | 1 |
| Eylan, E | 1 |
| Gazith, A | 1 |
| Shapiro, J | 1 |
| Naharin, S | 1 |
| Raanani, C | 1 |
| Gewant, WC | 1 |
| Goldenberg, IS | 1 |
| Lokich, JJ | 1 |
| Brooks, JR | 1 |
| Carter, SK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients Who Receiving Radical Concurrent Chemoradiotherapy and Immunotherapy: a Prospective, Randomized Controlled, Multicenter P[NCT04980716] | Phase 3 | 524 participants (Anticipated) | Interventional | 2021-06-01 | Recruiting | ||
| A Study of Preoperative FOLFIRINOX For Potentially Curable Pancreatic Cancer[NCT03167112] | Phase 2 | 20 participants (Anticipated) | Interventional | 2017-07-03 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for fluorouracil and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, In | 2012 |
L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU).
Topics: Adenocarcinoma, Mucinous; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Clinical Trials | 1977 |
Current therapy approaches of the Division of Cancer Treatment with emphasis on pancreatic carcinoma.
Topics: Adenocarcinoma; Animals; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Clinical Trials as Topi | 1974 |
61 other studies available for fluorouracil and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
[Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Int | 2013 |
Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 2015 |
Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.
Topics: Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2016 |
Pyrogallol, an absorbable microbial gallotannins-metabolite and mango polyphenols (Mangifera Indica L.) suppress breast cancer ductal carcinoma in situ proliferation in vitro.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Line, Tumor; Cell Proliferation; Cel | 2016 |
Successful pregnancy outcome with 5-flurouracil, epirubicin, cyclophosphamide chemotherapy, and hemostatic radiotherapy with abdominal shielding for metastatic invasive intraductal breast carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Non | 2009 |
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40).
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Brea | 2012 |
[Primary systemic therapy in breast cancer patients (2007-2010)].
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; | 2011 |
Increased dihydropyrimidine dehydrogenase activity in breast cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma | 2003 |
Fatal chemotherapy-induced encephalopathy following high-dose therapy for metastatic breast cancer: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain; Brain Diseases; Breast Neoplas | 2003 |
Fulminant lung metastases from cancer of the breast.
Topics: Adult; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cyclophosphamide; Female; Fluorour | 1981 |
[Clinical study on preoperative chemotherapy of primary breast cancer. 2--A comparative study of CPA + FT-207 (5-FUDS) and CPA + FT-207 (5-FUDS) + MMC].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; | 1983 |
[Antineoplastic effect of UFT therapy (uracil-FT-207 combination therapy) on experimental pancreatic cancer transplanted in the pancreas and subcutaneous region].
Topics: Animals; Antineoplastic Agents; Carcinoma, Intraductal, Noninfiltrating; Cricetinae; Drug Therapy, C | 1982 |
[Clinical trial on the effect of tegafur (SF-SP)].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Capsules; Carcinoma, Intraductal, Noninfiltrating | 1984 |
Self limited dermal invasion of keratinocytes in maculopapular eruptions after systemic chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Basement Membrane; Breast Neoplasms; Carcinoma, Intr | 1993 |
Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.
Topics: Actuarial Analysis; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Female; Fluo | 1993 |
Primary chemotherapy and radiosurgical breast-conserving treatment for patients with locally advanced operable breast cancers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, | 1993 |
Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; | 1993 |
Hormonal therapy in the treatment of mandibular metastasis of breast carcinoma. Report of a case.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, | 1993 |
P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltr | 2001 |
Invasive ductal carcinoma associated with tubular adenoma of the breast.
Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Carcinoma | 2002 |
Letter: Osteoblastic repair of osteolytic tumor metastases following treatment.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cyclophospham | 1975 |
Mastectomy as an adjunct to combination chemotherapy.
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Int | 1978 |
Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Ce | 1992 |
Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltr | 1992 |
Adjuvant chemotherapy in high-risk breast cancer patients with ten or more positive lymph nodes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltr | 1992 |
[Chromosomal restructurings and the distribution of chromosome fragile sites in the peripheral blood lymphocytes in a breast cancer patient after cytostatic therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltr | 1992 |
Comparison of partial and modified radical mastectomy in the community setting--"10 years later".
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Axilla; | 1992 |
Clinical trials referral resource. High priority trials--III. Breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carci | 1992 |
Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Non | 1991 |
Lack of correlation between histologic findings and response to chemotherapy in metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltr | 1991 |
[Platelet aggregation during adjuvant chemotherapy with CMF].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 1991 |
Comparison of long-term survival of 1986 consecutive patients with breast cancer treated at the National Cancer Institute of Milano, Italy (1971 to 1972 and 1977 to 1978).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noni | 1991 |
[Possibilities of the cytological method in the determination of therapeutic pathomorphosis of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma; Carcinoma, Intr | 1991 |
Treatment of digital ischaemia associated with chemotherapy using the prostacyclin analogue iloprost.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Female; Finger | 1991 |
Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Adhesion; Cell Division; Cell Moveme | 1991 |
[Chemotherapeutic pathomorphosis of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma; Carcinoma, Intr | 1990 |
[Results of treatment following breast-saving therapy: analysis of intramammary recurrence].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, | 1990 |
[Therapeutic effects of 9 antitumor drugs on stomach adenocarcinoma (MKN-28) in nude mice].
Topics: Animals; Antineoplastic Agents; Carcinoma, Intraductal, Noninfiltrating; Cisplatin; Cyclophosphamide | 1990 |
Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, | 1990 |
Long-term complete remission of stage IV breast cancer after high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms | 1990 |
5-Fluorouracil cardiotoxicity.
Topics: Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intrad | 1990 |
Multicentric reticulohistiocytosis and cancer: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arthritis; Breast Neoplasms; Carcinoma, Intraductal, | 1985 |
Tumor lysis syndrome in nonhematopoietic neoplasms.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Carcinoma, Intraductal, | 1989 |
[Therapeutic effect of stage III breast cancer--comparative study of preoperative intra-arterial infusion chemotherapy and non-infusion therapy].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ca | 1989 |
[Intra-arterial infusion chemotherapy of locally advanced and recurrent breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraducta | 1989 |
[Preoperative intensive chemotherapy of operable breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, | 1989 |
[Ablative hormone therapy and chemotherapy of metastatic breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltr | 1989 |
Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Non | 1988 |
[Clinical and histologic effects of preoperative combination chemotherapy of breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Intra | 1988 |
[Breast carcinoma and pregnancy. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Non | 1988 |
Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity.
Topics: Adult; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorouracil; Humans; Male | 1985 |
The response to further chemotherapy in patients with carcinoma of the breast who progressed while receiving adjuvant therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltr | 1985 |
Osteonecrosis of bone associated with combination chemotherapy without corticosteroids.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Non | 1986 |
Two cases with objective complete response to neo-adjuvant chemotherapy of breast carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noni | 1986 |
Effects of defined medium, fetal bovine serum, and human serum on growth and chemosensitivities of human breast cancer cells in primary culture: inference for in vitro assays.
Topics: Animals; Antineoplastic Agents; Blood; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Ca | 1987 |
The effect of chemotherapy on the morphology of human breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraducta | 1987 |
Cerebral venous sinus thrombosis in a patient receiving adjuvant chemotherapy for stage II breast cancer through an implanted central venous catheter.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noni | 1987 |
Tumor conference from University of Colorado Medical Center.
Topics: Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Castration; Diagnosis, Differential | 1970 |
Growth inhibiting effects of cytotoxic agents on human tumor and tumor-bearing normal tissue in vitro.
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Intra | 1971 |
Effect of drugs on carcinoma of the breast in tissue culture.
Topics: Adenofibroma; Biopsy; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Culture Techniques; | 1972 |
Disappearance of disseminated pancreatic carcinoma with combined chemotherapy.
Topics: Adult; Carcinoma, Intraductal, Noninfiltrating; Carmustine; Duodenum; Fluorouracil; Gastrectomy; Hum | 1973 |